CLINICAL_TRIALS
trial_result
· 2021-05-19
Clinical Trial Update: A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes [Phase 2]
Summary
Phase 2 trial update for tirzepatide (LY3298176) in adults with type 2 diabetes; study completed with results posted in 2021.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Type 2 Diabetes | Phase 2 | Status: COMPLETED | Results posted: 2021-05-19